These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25125468)

  • 1. Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model.
    Dunn HC; Ager RR; Baglietto-Vargas D; Cheng D; Kitazawa M; Cribbs DH; Medeiros R
    J Alzheimers Dis; 2015; 43(3):893-903. PubMed ID: 25125468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice.
    Medeiros R; Kitazawa M; Passos GF; Baglietto-Vargas D; Cheng D; Cribbs DH; LaFerla FM
    Am J Pathol; 2013 May; 182(5):1780-9. PubMed ID: 23506847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease.
    Kantarci A; Aytan N; Palaska I; Stephens D; Crabtree L; Benincasa C; Jenkins BG; Carreras I; Dedeoglu A
    Exp Neurol; 2018 Feb; 300():111-120. PubMed ID: 29126887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
    Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
    Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells.
    Wang YP; Wu Y; Li LY; Zheng J; Liu RG; Zhou JP; Yuan SY; Shang Y; Yao SL
    J Neuroinflammation; 2011 Aug; 8():95. PubMed ID: 21831303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neuroinflammatory effects of SLOH in Aβ-induced BV-2 microglial cells and 3xTg-AD mice involve the inhibition of GSK-3β.
    Wu X; Kosaraju J; Tam KY
    Neurosci Lett; 2018 Nov; 687():207-215. PubMed ID: 30278248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model.
    Kitazawa M; Cheng D; Tsukamoto MR; Koike MA; Wes PD; Vasilevko V; Cribbs DH; LaFerla FM
    J Immunol; 2011 Dec; 187(12):6539-49. PubMed ID: 22095718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-β and Tau Pathologies.
    Fanet H; Tournissac M; Leclerc M; Caron V; Tremblay C; Vancassel S; Calon F
    J Alzheimers Dis; 2021; 79(2):709-727. PubMed ID: 33337360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.
    Montgomery SL; Mastrangelo MA; Habib D; Narrow WC; Knowlden SA; Wright TW; Bowers WJ
    Am J Pathol; 2011 Oct; 179(4):2053-70. PubMed ID: 21835156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice.
    Janelsins MC; Mastrangelo MA; Park KM; Sudol KL; Narrow WC; Oddo S; LaFerla FM; Callahan LM; Federoff HJ; Bowers WJ
    Am J Pathol; 2008 Dec; 173(6):1768-82. PubMed ID: 18974297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockout of 5-lipoxygenase prevents dexamethasone-induced tau pathology in 3xTg mice.
    Joshi YB; Chu J; Praticò D
    Aging Cell; 2013 Aug; 12(4):706-11. PubMed ID: 23634895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bee venom phospholipase A2 ameliorates Alzheimer's disease pathology in Aβ vaccination treatment without inducing neuro-inflammation in a 3xTg-AD mouse model.
    Baek H; Lee CJ; Choi DB; Kim NS; Kim YS; Ye YJ; Kim YS; Kim JS; Shim I; Bae H
    Sci Rep; 2018 Nov; 8(1):17369. PubMed ID: 30478329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid receptors modulate dendritic spine plasticity and microglia activity in an animal model of Alzheimer's disease.
    Pedrazzoli M; Losurdo M; Paolone G; Medelin M; Jaupaj L; Cisterna B; Slanzi A; Malatesta M; Coco S; Buffelli M
    Neurobiol Dis; 2019 Dec; 132():104568. PubMed ID: 31394203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial Activation in the Retina of a Triple-Transgenic Alzheimer's Disease Mouse Model (3xTg-AD).
    Salobrar-García E; Rodrigues-Neves AC; Ramírez AI; de Hoz R; Fernández-Albarral JA; López-Cuenca I; Ramírez JM; Ambrósio AF; Salazar JJ
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
    Parkinson JF
    Inflamm Allergy Drug Targets; 2006 Apr; 5(2):91-106. PubMed ID: 16613568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age, sex and Alzheimer's disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients.
    Barber AJ; Del Genio CL; Swain AB; Pizzi EM; Watson SC; Tapiavala VN; Zanazzi GJ; Gaur AB
    Alzheimers Res Ther; 2024 Jun; 16(1):134. PubMed ID: 38909241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.